↓ Skip to main content

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent
5 patents

Readers on

mendeley
124 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
Published in
Clinical Cancer Research, April 2012
DOI 10.1158/1078-0432.ccr-11-2181
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 2%
Portugal 1 <1%
France 1 <1%
Spain 1 <1%
Germany 1 <1%
Colombia 1 <1%
Unknown 117 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 15 12%
Student > Ph. D. Student 15 12%
Researcher 14 11%
Student > Master 13 10%
Student > Doctoral Student 11 9%
Other 16 13%
Unknown 40 32%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 25 20%
Medicine and Dentistry 24 19%
Biochemistry, Genetics and Molecular Biology 11 9%
Immunology and Microbiology 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 8 6%
Unknown 47 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2020.
All research outputs
#3,379,912
of 23,372,952 outputs
Outputs from Clinical Cancer Research
#2,979
of 12,722 outputs
Outputs of similar age
#21,770
of 162,333 outputs
Outputs of similar age from Clinical Cancer Research
#32
of 128 outputs
Altmetric has tracked 23,372,952 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,722 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 162,333 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.